FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Pharmaceutical care in the treatment of diabetes

Farmaceutska zdravstvena zaštita u terapiji dijabetesa

Thumbnail
2011
1587.pdf (350.3Kb)
Authors
Vezmar-Kovačević, Sandra
Miljković, Branislava
Article (Published version)
Metadata
Show full item record
Abstract
Diabetes mellitus is characterized by impairment of insulin secretion and/or impairment of tissue sensitivity for insulin. The disease is chronic and associated with microvascular and macrovascular complications and a decreased quality of life. Treatment goals are based on the achievement of predefined glucose, blood pressure and lipid levels, using pharmacotherapy and nonpharmacological measures. Studies reveal many treatment problems such as adverse drug reactions, the presence of untreated indications, use of inadequate drug doses, low adherence, drug interactions etc. which may result in treatment failure. In contrast, treatment success is associated with patient education about the disease and the quality of medical care which is reflected in an interdisciplinary health strategy that stimulates the active role of the patient in disease control. Pharmacists can and must contribute in solving treatment problems and improving patient outcomes. Key activities of pharmacists are the ed...ucation of patients about adequate nutrition, drug use, prevention or mitigation of adverse drug reactions and interactions and improvement of adherence. Moreover, pharmacists should, periodically, evaluate treatment outcomes and search for new potential or actual treatment problems. Many studies showed that the aforementioned pharmacy activities contribute to improvement of patient outcomes in diabetes, increased productivity of patients and reduction of treatment costs.

Dijabetes melitus se karakteriše poremećajem u sekreciji insulina i/ili poremećajem osetljivosti tkiva na insulin. Bolest je hronična, udružena sa mikrovaskularnim i makrovaskularnim komplikacijama i umanjenim kvalitetom života. Terapijski ciljevi se zasnivaju na postizanju ciljnih vrednosti glukoze, krvnog pritiska i lipida, pomoću farmakoterapije i nefarmakoloških mera. Istraživanja pokazuju da su problemi u terapiji mnogobrojni poput ispoljavanja neželjenih reakcija na lek, postojanja nelečenih indikacija, primene neodgovarajućih doza lekova, nedovoljnog stepena adherence, interakcija i sl., dok je posledica navedenih problema, neretko, neuspeh terapije. Nasuprot tome, uspeh terapije zavisi od edukovanosti samog pacijenta o bolesti i kvaliteta zdravstvene zaštite koji se ogleda u postojanju interdisciplinarne zdravstvene strategije koja stimuliše aktivnu ulogu pacijenta u kontroli bolesti. Farmaceuti mogu i moraju pružiti doprinos rešavanju terapijskih problema i poboljšanju ishoda ...pacijenata. Od ključnih aktivnosti farmaceuta izdvajaju se edukacija pacijenata o pravilnom načinu ishrane, pravilnoj primeni terapije i prevenciji ili ublažavanju neželjenih reakcija i interakcija i poboljšanju stepena adherence. Takođe, dužnost je farmaceuta da periodično prati ishode terapije i procenjuje pojavu novih potencijalnih ili aktuelnih terapijskih problema. Mnogobrojna istraživanja pokazuju da navedene aktivnosti farmaceuta u značajnoj meri doprinose poboljšanju ishoda pacijenata sa dijabetesom, njihovoj povećanoj produktivnosti i smanjenju troškova lečenja.

Keywords:
diabetes / pharmaceutical care / treatment problems / education of patients / dijabetes / farmaceutska zdravstvena zaštita / terapijski problemi / edukacija pacijenata
Source:
Arhiv za farmaciju, 2011, 61, 4, 406-425
Publisher:
  • Savez farmaceutskih udruženja Srbije, Beograd

ISSN: 0004-1963

Scopus: 2-s2.0-80055040469
[ Google Scholar ]
Handle
https://hdl.handle.net/21.15107/rcub_farfar_1589
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/1589
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Vezmar-Kovačević, Sandra
AU  - Miljković, Branislava
PY  - 2011
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1589
AB  - Diabetes mellitus is characterized by impairment of insulin secretion and/or impairment of tissue sensitivity for insulin. The disease is chronic and associated with microvascular and macrovascular complications and a decreased quality of life. Treatment goals are based on the achievement of predefined glucose, blood pressure and lipid levels, using pharmacotherapy and nonpharmacological measures. Studies reveal many treatment problems such as adverse drug reactions, the presence of untreated indications, use of inadequate drug doses, low adherence, drug interactions etc. which may result in treatment failure. In contrast, treatment success is associated with patient education about the disease and the quality of medical care which is reflected in an interdisciplinary health strategy that stimulates the active role of the patient in disease control. Pharmacists can and must contribute in solving treatment problems and improving patient outcomes. Key activities of pharmacists are the education of patients about adequate nutrition, drug use, prevention or mitigation of adverse drug reactions and interactions and improvement of adherence. Moreover, pharmacists should, periodically, evaluate treatment outcomes and search for new potential or actual treatment problems. Many studies showed that the aforementioned pharmacy activities contribute to improvement of patient outcomes in diabetes, increased productivity of patients and reduction of treatment costs.
AB  - Dijabetes melitus se karakteriše poremećajem u sekreciji insulina i/ili poremećajem osetljivosti tkiva na insulin. Bolest je hronična, udružena sa mikrovaskularnim i makrovaskularnim komplikacijama i umanjenim kvalitetom života. Terapijski ciljevi se zasnivaju na postizanju ciljnih vrednosti glukoze, krvnog pritiska i lipida, pomoću farmakoterapije i nefarmakoloških mera. Istraživanja pokazuju da su problemi u terapiji mnogobrojni poput ispoljavanja neželjenih reakcija na lek, postojanja nelečenih indikacija, primene neodgovarajućih doza lekova, nedovoljnog stepena adherence, interakcija i sl., dok je posledica navedenih problema, neretko, neuspeh terapije. Nasuprot tome, uspeh terapije zavisi od edukovanosti samog pacijenta o bolesti i kvaliteta zdravstvene zaštite koji se ogleda u postojanju interdisciplinarne zdravstvene strategije koja stimuliše aktivnu ulogu pacijenta u kontroli bolesti. Farmaceuti mogu i moraju pružiti doprinos rešavanju terapijskih problema i poboljšanju ishoda pacijenata. Od ključnih aktivnosti farmaceuta izdvajaju se edukacija pacijenata o pravilnom načinu ishrane, pravilnoj primeni terapije i prevenciji ili ublažavanju neželjenih reakcija i interakcija i poboljšanju stepena adherence. Takođe, dužnost je farmaceuta da periodično prati ishode terapije i procenjuje pojavu novih potencijalnih ili aktuelnih terapijskih problema. Mnogobrojna istraživanja pokazuju da navedene aktivnosti farmaceuta u značajnoj meri doprinose poboljšanju ishoda pacijenata sa dijabetesom, njihovoj povećanoj produktivnosti i smanjenju troškova lečenja.
PB  - Savez farmaceutskih udruženja Srbije, Beograd
T2  - Arhiv za farmaciju
T1  - Pharmaceutical care in the treatment of diabetes
T1  - Farmaceutska zdravstvena zaštita u terapiji dijabetesa
VL  - 61
IS  - 4
SP  - 406
EP  - 425
UR  - https://hdl.handle.net/21.15107/rcub_farfar_1589
ER  - 
@article{
author = "Vezmar-Kovačević, Sandra and Miljković, Branislava",
year = "2011",
abstract = "Diabetes mellitus is characterized by impairment of insulin secretion and/or impairment of tissue sensitivity for insulin. The disease is chronic and associated with microvascular and macrovascular complications and a decreased quality of life. Treatment goals are based on the achievement of predefined glucose, blood pressure and lipid levels, using pharmacotherapy and nonpharmacological measures. Studies reveal many treatment problems such as adverse drug reactions, the presence of untreated indications, use of inadequate drug doses, low adherence, drug interactions etc. which may result in treatment failure. In contrast, treatment success is associated with patient education about the disease and the quality of medical care which is reflected in an interdisciplinary health strategy that stimulates the active role of the patient in disease control. Pharmacists can and must contribute in solving treatment problems and improving patient outcomes. Key activities of pharmacists are the education of patients about adequate nutrition, drug use, prevention or mitigation of adverse drug reactions and interactions and improvement of adherence. Moreover, pharmacists should, periodically, evaluate treatment outcomes and search for new potential or actual treatment problems. Many studies showed that the aforementioned pharmacy activities contribute to improvement of patient outcomes in diabetes, increased productivity of patients and reduction of treatment costs., Dijabetes melitus se karakteriše poremećajem u sekreciji insulina i/ili poremećajem osetljivosti tkiva na insulin. Bolest je hronična, udružena sa mikrovaskularnim i makrovaskularnim komplikacijama i umanjenim kvalitetom života. Terapijski ciljevi se zasnivaju na postizanju ciljnih vrednosti glukoze, krvnog pritiska i lipida, pomoću farmakoterapije i nefarmakoloških mera. Istraživanja pokazuju da su problemi u terapiji mnogobrojni poput ispoljavanja neželjenih reakcija na lek, postojanja nelečenih indikacija, primene neodgovarajućih doza lekova, nedovoljnog stepena adherence, interakcija i sl., dok je posledica navedenih problema, neretko, neuspeh terapije. Nasuprot tome, uspeh terapije zavisi od edukovanosti samog pacijenta o bolesti i kvaliteta zdravstvene zaštite koji se ogleda u postojanju interdisciplinarne zdravstvene strategije koja stimuliše aktivnu ulogu pacijenta u kontroli bolesti. Farmaceuti mogu i moraju pružiti doprinos rešavanju terapijskih problema i poboljšanju ishoda pacijenata. Od ključnih aktivnosti farmaceuta izdvajaju se edukacija pacijenata o pravilnom načinu ishrane, pravilnoj primeni terapije i prevenciji ili ublažavanju neželjenih reakcija i interakcija i poboljšanju stepena adherence. Takođe, dužnost je farmaceuta da periodično prati ishode terapije i procenjuje pojavu novih potencijalnih ili aktuelnih terapijskih problema. Mnogobrojna istraživanja pokazuju da navedene aktivnosti farmaceuta u značajnoj meri doprinose poboljšanju ishoda pacijenata sa dijabetesom, njihovoj povećanoj produktivnosti i smanjenju troškova lečenja.",
publisher = "Savez farmaceutskih udruženja Srbije, Beograd",
journal = "Arhiv za farmaciju",
title = "Pharmaceutical care in the treatment of diabetes, Farmaceutska zdravstvena zaštita u terapiji dijabetesa",
volume = "61",
number = "4",
pages = "406-425",
url = "https://hdl.handle.net/21.15107/rcub_farfar_1589"
}
Vezmar-Kovačević, S.,& Miljković, B.. (2011). Pharmaceutical care in the treatment of diabetes. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije, Beograd., 61(4), 406-425.
https://hdl.handle.net/21.15107/rcub_farfar_1589
Vezmar-Kovačević S, Miljković B. Pharmaceutical care in the treatment of diabetes. in Arhiv za farmaciju. 2011;61(4):406-425.
https://hdl.handle.net/21.15107/rcub_farfar_1589 .
Vezmar-Kovačević, Sandra, Miljković, Branislava, "Pharmaceutical care in the treatment of diabetes" in Arhiv za farmaciju, 61, no. 4 (2011):406-425,
https://hdl.handle.net/21.15107/rcub_farfar_1589 .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB